J. Daniel  Plants net worth and biography

J. Plants Biography and Net Worth

Director of Cutera
J. Daniel Plants was appointed Executive Chairman of the Company's Board of Directors in May 2021.  He previously served as Independent Chairman from October 2016 through May 2021 and has been a member of the Board since January 2015. Mr. Plants has been Managing Partner of Voce Capital Management LLC since 2009. Prior to founding Voce Capital Management, Mr. Plants held a number of positions at leading Wall Street firms, including executive roles in investment banking at Goldman Sachs and JPMorgan Chase, and as a corporate attorney with Sullivan & Cromwell. Mr. Plants co-founded The Bay Area Urban Debate League and served as its Vice Chairman from 2008 to 2012. Mr. Plants holds a Juris Doctorate degree from University of Michigan Law School and an undergraduate degree from Baylor University.

What is J. Daniel Plants' net worth?

The estimated net worth of J. Daniel Plants is at least $9,218.44 as of August 13th, 2021. Mr. Plants owns 28,105 shares of Cutera stock worth more than $9,218 as of December 27th. This net worth approximation does not reflect any other assets that Mr. Plants may own. Learn More about J. Daniel Plants' net worth.

How do I contact J. Daniel Plants?

The corporate mailing address for Mr. Plants and other Cutera executives is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. Cutera can also be reached via phone at (415) 657-5500 and via email at [email protected]. Learn More on J. Daniel Plants' contact information.

Has J. Daniel Plants been buying or selling shares of Cutera?

J. Daniel Plants has not been actively trading shares of Cutera within the last three months. Most recently, on Monday, August 16th, J Daniel Plants bought 1,000 shares of Cutera stock. The stock was acquired at an average cost of $47.99 per share, with a total value of $47,990.00. Following the completion of the transaction, the director now directly owns 28,105 shares of the company's stock, valued at $1,348,758.95. Learn More on J. Daniel Plants' trading history.

Who are Cutera's active insiders?

Cutera's insider roster includes David Mowry (CEO), Timothy Oshea (Director), J. Plants (Director), Rohan Seth (CFO), Joseph Whitters (Director), and Katherine Zanotti (Director). Learn More on Cutera's active insiders.

Are insiders buying or selling shares of Cutera?

During the last year, insiders at the medical device company sold shares 2 times. They sold a total of 35,788 shares worth more than $91,172.20. The most recent insider tranaction occured on May, 16th when EVP Michael Karavitis sold 24,940 shares worth more than $64,594.60. Insiders at Cutera own 0.4% of the company. Learn More about insider trades at Cutera.

Information on this page was last updated on 5/16/2024.

J. Daniel Plants Insider Trading History at Cutera

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/16/2021Buy1,000$47.99$47,990.0028,105View SEC Filing Icon  
8/13/2021Buy1,000$49.99$49,990.0028,105View SEC Filing Icon  
5/17/2021Buy664,828$29.50$19,612,426.0023,020View SEC Filing Icon  
8/19/2020Buy59,769$14.90$890,558.1023,020View SEC Filing Icon  
8/17/2020Buy11,540$14.87$171,599.8023,020View SEC Filing Icon  
4/21/2020Buy95,238$10.50$999,999.0015,873View SEC Filing Icon  
3/6/2020Buy8,900$21.82$194,198.0015,873View SEC Filing Icon  
3/2/2020Buy23,855$24.13$575,621.1515,873View SEC Filing Icon  
2/28/2020Buy26,005$24.20$629,321.0015,873View SEC Filing Icon  
6/12/2019Buy200$16.47$3,294.0010,287View SEC Filing Icon  
6/3/2019Buy28,166$16.73$471,217.18View SEC Filing Icon  
5/31/2019Buy14,011$16.93$237,206.23View SEC Filing Icon  
5/14/2019Buy7,145$16.95$121,107.75View SEC Filing Icon  
3/13/2017Sell250,000$20.25$5,062,500.005,550View SEC Filing Icon  
See Full Table

J. Daniel Plants Buying and Selling Activity at Cutera

This chart shows J Daniel Plants's buying and selling at Cutera by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cutera Company Overview

Cutera logo
Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform. It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and Enlighten SR/III, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars. In addition, the company provides Excel HR, a hair removal solution for all skin types; xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity; and Secret DUO, two dual non-ablative fractional technologies that can be used individually or in combination to target a variety of aesthetic concerns and skin conditions on all skin types with little to no downtime. Further, it offers its products through direct sales and services, and network of distributors and direct international sales. Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.
Read More

Today's Range

Now: $0.33
Low: $0.30
High: $0.33

50 Day Range

MA: $0.44
Low: $0.29
High: $0.72

2 Week Range

Now: $0.33
Low: $0.28
High: $4.97

Volume

596,287 shs

Average Volume

840,144 shs

Market Capitalization

$6.62 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.26